HEART ABNORMALITIES IN VASCULAR ENDOTHELIAL GROWTH FACTOR B (VEGF-B) DEFICIENT ANIMALS AND METHODS RELATING TO THESE HEART ABNORMALITIES - Patent 1166102

(19)

(11)

EP 1 166 102 A1

(12)

(43)	Date of publication:
	02.01.2002 Bulletin 2002/01

(21)	Application number: 00914803.2

(22)	Date of filing: 03.03.2000

(51)	International Patent Classification (IPC)⁷: G01N 33/00, A01N 43/04, A61K 38/00, A61K 39/395, A61K 39/40, A61K 39/42, A61K 39/44, C07H 21/02, C07H 21/04, C12N 15/00, C12N 15/09, C12P 19/34

(86)	International application number:
	PCT/US0005/465

(87)	International publication number:
	WO 0052/462 (08.09.2000 Gazette 2000/36)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30)

Priority:

03.03.1999 US 160083 P

(71)	Applicant: LUDWIG INSTITUTE FOR CANCER RESEARCH
	New York, New York 10158 (US)

(72)	Inventors:
	AASE, Karin,Ludwig Institute for Cancer Research S-171 77 Stockholm (SE) THOREN, Peter,Karolinska Institute S-171 77 Stockholm (SE) ERIKSSON, Ulf,Ludwig Institute Cancer Research S-171 77 Stockholm (SE)

(74)	Representative: Harrison Goddard Foote
	Belgrave Hall Belgrave Street Leeds LS2 8DD Leeds LS2 8DD (GB)

(54)	HEART ABNORMALITIES IN VASCULAR ENDOTHELIAL GROWTH FACTOR B (VEGF-B) DEFICIENT ANIMALS AND METHODS RELATING TO THESE HEART ABNORMALITIES